A small, early-stage study published in the journal Headache suggested a diabetes drug may ease migraines by lowering ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...

Liraglutide, a medication commonly used to treat diabetes, has shown promising results in reducing chronic migraine in ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

For more health information, please see recent studies about Vitamin D that may reduce dangerous complications in diabetes and results showing plant-based protein foods may help reverse type 2 ...

A diabetes medication that lowers brain fluid pressure has cut monthly migraine days by more than half, according to a new ...

A GLP-1 drug led to fewer days with headaches, a small pilot study of migraine sufferers shows. It may work by lowering pressure inside the head.

Subsequent hospitalization rates were lower among patients with type 2 diabetes who received liraglutide compared with glimepiride.

Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.